votrient

Introduction to votrient

Votrient is a medication primarily used in the form of tablets to treat certain types of cancer. Votrient is specifically indicated for advanced renal cell carcinoma and soft tissue sarcoma, which are cancers that affect the kidney and connective tissues, respectively.

Composition of votrient

Votrient contains the active ingredient Pazopanib, which is a type of medication known as a tyrosine kinase inhibitor. This compound works by blocking specific proteins that promote the growth and spread of cancer cells.

Uses of votrient

• Advanced renal cell carcinoma
• Soft tissue sarcoma

Side effects of votrient

• Common side effects: Fatigue, nausea, diarrhea, changes in hair color
• Serious side effects: Liver problems, high blood pressure

Precautions of votrient

Patients taking Votrient should undergo regular liver function tests due to potential liver issues. Monitoring blood pressure is also crucial as Votrient can cause hypertension. It is not recommended for individuals with severe liver problems or for pregnant women.

How to Take votrient

Votrient is typically taken as a tablet. The usual starting dose for adults is 800 mg once daily. It should be taken on an empty stomach, at least one hour before or two hours after a meal. The tablet must be swallowed whole with water. Always follow your doctor's instructions regarding dosage and administration.

Conclusion of votrient

Votrient, containing the active ingredient Pazopanib, belongs to the therapeutic class of tyrosine kinase inhibitors. It is manufactured for the treatment of advanced renal cell carcinoma and soft tissue sarcoma. Key highlights include its role in inhibiting cancer cell growth and the necessity for regular monitoring of liver function and blood pressure. Votrient is a critical option for managing specific cancer types effectively.